ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease that has classically been grouped based on the expression of estrogen receptor (ER) and progesterone receptor (PR) as well as the overexpression of human epidermal growth factor receptor 2 (HER2) in tumors.